This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
William G. Couser. Primary Membranous Nephropathy. CJASN June 07, 2017 12: (6) 983–997; published ahead of print May 26, 2017, doi:10.2215/CJN.11761116.
Due to author error, two doses were incorrectly reported in Table 6 of the above referenced article. The doses in the text are correct. The correct doses for Table 6 are:
Summary of the most common IST protocols for treating patients with primary membranous nephropathy (56–60,93)
The dose of Rituximab is 375 mg/M2.
The dose of Prednisone with Cyclosporin is 5–10 mg.
Footnotes
Published online ahead of print. Publication date available at www.cjasn.org.
- Copyright © 2017 by the American Society of Nephrology
In this issue
Jump to section
More in this TOC Section
Cited By...
- No citing articles found.